Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.4B | 4.3B | 4.6B | 2.3B |
Cost of revenue | 1.7B | 3.5B | 2.3B | 1.4B |
Gross profit | 1.7B | 860.1M | 2.3B | 895.1M |
Operating expense | ||||
Research & development | 465.8M | 504.3M | 508.8M | 504.1M |
Selling general and admin | 221.8M | 189.2M | 103.9M | 171.0M |
Other operating expenses | 17.2M | 154.0M | 7.9M | 8.6M |
Operating income | 700.7M | -277.5M | 1.3B | -116.4M |
Non operating interest income | ||||
Income | 93.5M | 77.7M | 46.3M | 54.6M |
Expense | 33.8M | 56.7M | 92.5M | 87.8M |
Other income expense | — | — | — | — |
Pretax income | 749.9M | -451.9M | 1.2B | 200.5M |
Tax provision | 13.6M | — | — | — |
Net income | 736.2M | -511.8M | 1.2B | 200.5M |
Basic EPS | 57 | — | 104 | 18 |
Diluted EPS | 57 | — | 104 | -1 |
Basic average shares | 12.9M | — | 11.4M | 11.1M |
Diluted average shares | 12.9M | — | 11.4M | — |
EBITDA | 1.1B | 389.3M | 1.6B | 337.4M |
Net income from continuing op. | 736.2M | -511.8M | 1.2B | 200.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |